Keynote: "How big data, artificial intelligence, pharmaceutical and medical research combine to tackle cancer?"
Tina rejoined Pfizer in September 2017, bringing with her over 20 years of
leadership experience at five top-tier global pharmaceutical companies in several European countries and the US, spanning global, regional as well as local roles.
As VP of Strategy for Pfizer Oncology IDM, she is now responsible for identifying, evaluating, and addressing short and long-term strategic and business opportunities across the entire portfolio and the diverse set of close to 50 markets.
Tina joined Pfizer from Novartis Oncology Region Europe, where for almost six years, she held the position of Chief Commercial Officer, responsible for regional product strategy and execution across 39 markets, leading the launch of more than ten new oncology products. She also initiated and led strategic projects including one that resulted a new regional “Go To Market model” and another that created a new commercial model for the CAR-T cell therapy in Europe.
Prior to joining Novartis, Tina worked from 2006-2011 for Amgen where she was the General Manager for Switzerland and in 2009 became the Executive Director of International Marketing in Oncology.
Earlier in her career, Tina spent 10 years in research and development in roles of increasing responsibility, leading the New Products Development team with Roche for 3 years, then joining Warner Lambert to support the clinica development program for several programs including later blockbusters such as Lipitor, Neurontin and Lyrica across the EU, South Africa and Australia and later globally.
Following Pfizer’s acquisition of Warner Lambert in 2000, Tina was appointed Director for Global Program Management, based in Michigan, USA, with responsibility for numerous global teams and working across a variety of therapy areas including oncology. Following other roles with increasing responsibilities in sales management, business development and strategic planning, Tina ultimately assumed the role of Business Unit Director for Pfizer Oncology in Germany.
Tina holds a Master Degree in Pharmacy from the University of Heidelberg and an Executive MBA from Michigan State University.